Treg Modulation With CD28 and IL-6 Receptor Antagonists
Clinical trial NCT04066114 · COMPLETED
Trial details
- NCT number
- NCT04066114
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-11
- Primary completion
- 2023-09-14
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.